64
Medeon Biodesign, Inc.
6499.TWO · TWO
$70.00 -1.82% (-$1.30)
1M +12.64%
Market Cap $6.93B
P/E Ratio -
Div. Yield -
ROE 46.17%
Piotroski F-Score Moderate
4/9Valuation
18 /100
Expensive P/B 5.10x
P/S 16.19x
EV/FFO N/A
Growth
58 /100
Stable Book val. growth 25.70%
Rev. growth 12.03%
FCF growth N/A
Profitability
1 /100
Weak Op. margin 144.73%
Gross margin 9.16%
FCF margin 131.72%
Quality
3 /100
Poor ROA 35.13%
ROIC 39.18%
Asset turnover 0.25x
Debt
69 /100
Low Int. coverage -208.23x
Debt/Equity 0.12x
Current ratio 8.21x
Stability
24 /100
Unstable EPS volatility 117.54%
Beta 0.58x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 6499.TWO
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Yu Te Chang
Employees
1,496
Headquarters
Taipei
Evenimente viitoare
29 OCT.
Earnings
Upcoming earnings report